Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology.
Fibralign Corp. and leading physicians presented an update on clinical findings and case studies during the 30th World Congress of the International Society of Lymphology (ISL), held 15–19 October 2025 in Antalya, Turkey.
Dr. Corrado Campisi presented his prospective randomized clinical study using BioBridge with advanced microsurgical procedures.